Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC4189213(R),14(R)-epoxy Fluprostenol isopropyl esterCAS: 2557329-36-7纯度: >95.00%
Travoprost impurity
- GC4189313(R)-HODE cholesteryl esterCAS: 330800-94-7纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
- GC4189513(S)-HODE cholesteryl esterCAS: 141554-21-4纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
- GC4189913(S)-HpOTrECAS: 67597-26-6纯度: >98.00%
A product of soybean LO-2 metabolism of α-linolenic acid
- GC4190213,14-dihydro Prostaglandin F1αCAS: 20592-20-5纯度: >99.00%
A potential metabolite of PGF 1α
- GC4190313,14-dihydro-15-keto-tetranor Prostaglandin F1αCAS: 24379-94-0纯度: >98.00%
Potential metabolite of PGF 1α and PGF 2α
- GC4190413,14-dihydro-15-keto-tetranor Prostaglandin F1βCAS: 23015-45-4纯度: >98.00%
A major urinary metabolite of PGE 2
- GC4190713C C16 Sphingomyelin (d18:1/16:0)CAS: 144236-99-7纯度: >98.00%
An internal standard for the quantification of C16 sphingomyelin
- GC4190813C6 Glucosylsphingosine (d18:1)CAS: 299172-48-8纯度: >98.00%
An internal standard for the quantification of 1-β-D-glucosylsphingosine
- GC4191113-epi-12-oxo Phytodienoic AcidCAS: 71606-07-0纯度: >95.00%
A lipoxygenase metabolite of α-linolenic acid
- GC4191213-methyl Pentadecanoic Acid methyl esterCAS: 5487-50-3纯度: >98.00%
A methylated fatty acid methyl ester
- GC4191814-methyl Pentadecanoic Acid methyl esterCAS: 5129-60-2纯度: >98.00%
A methylated fatty acid methyl ester
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41892 | 13(R),14(R)-epoxy Fluprostenol isopropyl ester | 2557329-36-7 | >95.00% | |
Travoprost impurity | ||||
| GC41893 | 13(R)-HODE cholesteryl ester | 330800-94-7 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||
| GC41894 | 13(S),14(S)-epoxy Fluprostenol isopropyl ester | - | >95.00% | |
Travoprost impurity | ||||
| GC41895 | 13(S)-HODE cholesteryl ester | 141554-21-4 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||
| GC41897 | 13(S)-HOTrE | 87984-82-5 | >98.00% | |
A 15-LO product derived from GLA | ||||
| GC41898 | 13(S)-HOTrE(γ) | 74784-20-6 | >98.00% | |
A 15-LO product derived from GLA | ||||
| GC41899 | 13(S)-HpOTrE | 67597-26-6 | >98.00% | |
A product of soybean LO-2 metabolism of α-linolenic acid | ||||
| GC41901 | 13(Z)-Docosenoic Acid methyl ester | 1120-34-9 | >95.00% | |
A fatty acid methyl ester | ||||
| GC41902 | 13,14-dihydro Prostaglandin F1α | 20592-20-5 | >99.00% | |
A potential metabolite of PGF 1α | ||||
| GC41903 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | 24379-94-0 | >98.00% | |
Potential metabolite of PGF 1α and PGF 2α | ||||
| GC41904 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | 23015-45-4 | >98.00% | |
A major urinary metabolite of PGE 2 | ||||
| GC41905 | 13,14-dihydro-16,16-difluoro Prostaglandin E1 | 475992-30-4 | >98.00% | |
Analog of PGE 1 | ||||
| GC41906 | 13,14-epoxy Fluprostenol isopropyl ester | 2557327-99-6 | >95.00% | |
Travoprost impurity | ||||
| GC41907 | 13C C16 Sphingomyelin (d18:1/16:0) | 144236-99-7 | >98.00% | |
An internal standard for the quantification of C16 sphingomyelin | ||||
| GC41908 | 13C6 Glucosylsphingosine (d18:1) | 299172-48-8 | >98.00% | |
An internal standard for the quantification of 1-β-D-glucosylsphingosine | ||||
| GC41910 | 13-Docosenamide | 112-84-5 | >98.00% | |
The amide of docosenoic acid | ||||
| GC41911 | 13-epi-12-oxo Phytodienoic Acid | 71606-07-0 | >95.00% | |
A lipoxygenase metabolite of α-linolenic acid | ||||
| GC41912 | 13-methyl Pentadecanoic Acid methyl ester | 5487-50-3 | >98.00% | |
A methylated fatty acid methyl ester | ||||
| GC41913 | 13-OAHSA | 1997286-67-5 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41914 | 13-OxoODE | 54739-30-9 | >95.00% | |
The product of NAD + -dependent dehydrogenase activity on 13-HODE | ||||
| GC41915 | 13-POHSA | 2126038-97-7 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41916 | 13-SAHSA | 2108907-29-3 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41917 | 14-methyl Palmitic Acid | 5918-29-6 | >98.00% | |
A methylated fatty acid | ||||
| GC41918 | 14-methyl Pentadecanoic Acid methyl ester | 5129-60-2 | >98.00% | |
A methylated fatty acid methyl ester | ||||